Mochida Pharmaceutical Co., Ltd. produces and sells pharmaceuticals, skincare products, and diagnostics solutions in Japan. The company provides cardiovascular, analgesic, gastrointestinal, neurological, anti-infective, antidiabetics, and anticancer products, as well as hormone and biological preparations, and biosimilars; diagnostic reagents, such as reagents for fertility/infertility and other reagents; and face and body care, hair care, and skincare products, as well as dermatology, psychiatry, obstetrics, and gynecology products. It also developing drugs for the treatment of intractable diseases. The company has collaboration agreements with Amarin Corporation plc for the development and commercialization of ethyl icosapentate products; and Gene Techno Science Co., Ltd. to develop new regenerative medicine for the treatment of digestive rare and intractable diseases, such as congenital isolated hypoganglionosis. Mochida Pharmaceutical Co., Ltd. was founded in 1913 and is headquartered in Tokyo, Japan.

Mochida Pharmaceutical Co., Ltd.

持田製薬株式会社 develops and sells pharmaceuticals and healthcare products. The company's offerings include skin care products and patient information websites, as well as services aimed at supporting various medical conditions.

JP:CO:MOCHIDA

持田製薬株式会社

Last Close

3,235.00

14/02 06:30

Market Cap

117.88B

Beta: -

Volume Today

14.30K

Avg: -